1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Personalized Medicine Market Analysis

Personalized Medicine Market Analysis

  • May 2013
  • -
  • RNCOS
  • -
  • 90 pages

Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as per individuals. The growing research applications and identification of molecular markers towards disease predisposition and progression have led to the growth of personalized medicine. Industry players have also rapidly adopted this field and are progressing towards achieving higher goals in the same.

According to our new research report, “Personalized Medicine Market Analysis”, the U.S. represents the brightest market for personalized medicine and is anticipated to grow at a CAGR of around 9.5% during 2012-2017. The need for rapid detection of diseases, especially cancer,and their more efficient treatments are primarily driving this market.

Besides USA, countries like the U.K., France, Germany, India, China, and Japan have also been trying to pioneer personalized medicine with the help of advanced technologies. A lot of investment has been undergoing for research and development to develop biomarkers and personalized healthcare solutions in order to improve the medical outcomes. Our report provides a prudent analysis at the country level, elucidating the level of personalized medicine penetration, recent industry developments and the future growth prospects.

Companies are actively involved in the development of advanced technological tools and diagnostic equipments that help in promoting personalized medicine. Strategic alliances and consolidation has also become a common trend towards greater market presence. Academic and private research institutions as well as small biotech and major pharmaceutical companies are increasingly looking for alternative ways to strengthen their pipelines. The report highlights the various strategies being adopted by market players and research institutes to promote growth in this field.

The report also covers the industry positioning in terms of the major therapeutic areas. The study also provides an insight into the segment-wise competitive landscape, which includes the profiles of Pharmaceutical/Biotech, Diagnostic, IT/Informatics, and Research Tool companies across the globe. Through the report, companies planning to venture into the personalized medicine sector will also have an in-depth understanding of the industry dynamics.

Table Of Contents

Personalized Medicine Market Analysis
1. Analyst View
2. Research Methodology
3. Personalized Medicine Market: An Introduction
4. Personalized Medicine Market
4.1 Therapeutics
4.1.1 Cancer
4.1.2 Cardiovascular Diseases
4.1.3 Neurological Disorders
4.2 Diagnostics
5. Market Participants
5.1 Pharmaceutical Companies
5.2 Diagnostic Companies
5.3 Technology Providers
5.4 Healthcare Providers
5.5 Insurance Companies
6. Key Geographical Markets
6.1 US
6.2 Europe
6.3 Emerging Markets
6.3.1 Japan
6.3.2 China
6.3.3 India
7. Market Drivers and Restraints
7.1 Drivers
7.1.1 Increasing Focus of Personalized Medicine in Cancer
7.1.2 Robust Advancements in Pharmacogenomics and Pharmacogenetics
7.1.3 Personalization for Prevention of ADR's
7.1.4 Healthcare Costs Savings
7.2 Restraints
7.2.1 Reimbursement
7.2.2 Privacy, Confidentiality and Patients' Rights
8. Regulatory Environment
9. Competitive Landscape
9.1 Pharma/Biotech Companies
9.1.1 Abbott Laboratories
9.1.2 Genzyme Corporation
9.1.3 Novartis AG
9.1.4 Bristol-Myers Squibb Company
9.2 IT/Informatics Companies
9.2.1 IBM
9.2.2 Oracle Health Sciences
9.2.3 XIFIN, Inc.
9.2.4 CTIS, Inc.
9.3 Diagnostic Companies
9.3.1 Siemens
9.3.2 Roche
9.3.3 Rosetta Genomics Ltd.
9.3.4 QIAGEN N.V.
9.3.5 Gen-Probe Incorporated
9.3.6 Dako Denmark A/S
9.3.7 BioMerieux SA
9.4 Research Tool Companies
9.4.1 Affymetrix, Inc.
9.4.2 DNA Genotek
9.4.3 Illumina, Inc.
9.4.4 Life Technologies Corporation
9.4.5 Pacific Biosciences

List of Figures:

Figure 6-1: US - Personalized Medicine Market (Billion US$), 2012-2017
Figure 6-2: US - Personalized Medicine Market by Segment (%), 2012

List of Tables:

Table 4-1: Personalized Medicine for Cancer by Therapy (2011)
Table 4-2: Personalized Medicine for Cardiovascular Diseases by Therapy (2011)
Table 4-3: Personalized Medicine for Neurological Disorders by Therapy (2011)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Global Personalized Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts

Global Personalized Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts

  • $ 3 495
  • Industry report
  • June 2015
  • by Currentpartnering

The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee ...

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

  • $ 3 400
  • Industry report
  • July 2015
  • by Kelly Scientific Publications

Cutting-edge new research by KellySciPub indicates that the core personalized medicine market will be worth over $60 billion by 2019. This market is made up of companion diagnostics and targeted therapeutics ...

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015  - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

  • $ 3 400
  • Industry report
  • February 2015
  • by Kelly Scientific Publications

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 270 tables ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • June 2015
    4 pages
  • Diagnostic  

  • United States  

View report >

Global Oncology Markets

  • May 2015
    51 pages
  • Cancer Therapy  

    Healthcare  

    Oncology  

  • United States  

    World  

View report >

Pathology Description - Forecast

  • January 2015
    4 pages
  • Cancer  

    Personalized Me...  

  • United States  

    United Kingdom  

    Europe  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.